Clinical Trial Update: Efficacy and Safety of Intravenous Meloxicam in Subjects With Moderate-to-severe Pain Following Abdominal Surgery [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the efficacy and safety of intravenous meloxicam for acute moderate-to-severe postoperative pain after abdominal surgery; the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Pain

Drugs mentioned

• Meloxicam (intravenous) (meloxicam)

Snippet

Sponsor: Yangtze River Pharmaceutical Group Co., Ltd. | Conditions: Participants With Acute Moderate to Severe Pain Following Abdominal Surgery | Phase 3 | Status: COMPLETED